Inso Biosciences
Ithaca, US · Founded 2018 · Delaware corporation · 4 known investors
Founders & leadership
HC
Harvey Chen TianExecutive
Board
AB
Adam BisogniBoard director
Investors · 4
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 2 rounds · 2022–2026
▶$750KraisedApr 2026 · 9 investors · BiotechnologyRule 506(b)
▶$750KraisedApr 2026 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adam BisogniDirector
- Harvey Chen TianExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $750K
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedFeb 2022 · 4 investors · BiotechnologyRule 506(b)
▶$1.8MraisedFeb 2022 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adam BisogniDirector
- Harvey TianExecutive Officer, Director
- Offering amount
- $2.3M
- Amount sold
- $1.8M
- Minimum investment
- $200K
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Inso Biosciences's investors?
- Inso Biosciences's investors include 2048 Ventures, CRCM Ventures, SOSV, Whitecap Venture Partners.
- How much funding has Inso Biosciences raised?
- Inso Biosciences has disclosed $2.5M raised across 2 rounds.
- Where is Inso Biosciences headquartered?
- Inso Biosciences is headquartered in Ithaca, US.